Omran Heyder, Tzikas Apostolos, Sievert Horst, Stock Frederike
Department of Cardiology, GFO Kliniken Bonn, Robert-Koch-Str. 1, Bonn 53115, Germany.
Department of Cardiology, AHEPA University Hospital, Kiriakidi 1 Street, Thessaloniki 54637, Greece.
Interv Cardiol Clin. 2018 Apr;7(2):137-142. doi: 10.1016/j.iccl.2017.12.009.
Percutaneous left atrial appendage occlusion was introduced as an alternative method for prevention of thromboembolism in patients with nonvalvular atrial fibrillation after extensive animal work in 2001. The first device was named Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO) and patented by the company Appriva. The device was invented by Michael Lesh, MD.
2001年，在大量动物实验后，经皮左心耳封堵术作为预防非瓣膜性心房颤动患者血栓栓塞的一种替代方法被引入。首个装置被命名为经皮左心耳导管封堵术（PLAATO），并由Appriva公司获得专利。该装置由医学博士迈克尔·莱什发明。
